G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $926 | -57.5% | 643 | -26.6% | 0.00% | – |
| Q2 2023 | $2,181 | -50.8% | 876 | -47.1% | 0.00% | – |
| Q1 2023 | $4,435 | -96.7% | 1,655 | -93.2% | 0.00% | – |
| Q4 2022 | $132,514 | -91.7% | 24,404 | -80.8% | 0.00% | -100.0% |
| Q3 2022 | $1,590,000 | +26400.0% | 127,309 | +10404.0% | 0.00% | – |
| Q2 2022 | $6,000 | -98.1% | 1,212 | -97.1% | 0.00% | – |
| Q1 2022 | $320,000 | -88.3% | 42,054 | -84.3% | 0.00% | -100.0% |
| Q4 2021 | $2,728,000 | +47.8% | 267,173 | +94.2% | 0.00% | 0.0% |
| Q3 2021 | $1,846,000 | -54.7% | 137,557 | -26.0% | 0.00% | -50.0% |
| Q2 2021 | $4,076,000 | -4.0% | 185,801 | +5.3% | 0.00% | -33.3% |
| Q1 2021 | $4,246,000 | +2788.4% | 176,465 | +2062.3% | 0.00% | – |
| Q4 2020 | $147,000 | +297.3% | 8,161 | +151.6% | 0.00% | – |
| Q3 2020 | $37,000 | -93.6% | 3,243 | -86.4% | 0.00% | – |
| Q2 2020 | $577,000 | +86.1% | 23,798 | -15.4% | 0.00% | – |
| Q1 2020 | $310,000 | -4.6% | 28,135 | +128.7% | 0.00% | – |
| Q4 2019 | $325,000 | -47.6% | 12,300 | -54.8% | 0.00% | – |
| Q3 2019 | $620,000 | +35.1% | 27,197 | +81.6% | 0.00% | – |
| Q2 2019 | $459,000 | +94.5% | 14,976 | +5.4% | 0.00% | – |
| Q1 2019 | $236,000 | -89.1% | 14,206 | -87.4% | 0.00% | -100.0% |
| Q4 2018 | $2,156,000 | +18.6% | 112,585 | +223.9% | 0.00% | 0.0% |
| Q3 2018 | $1,818,000 | +87.6% | 34,764 | +55.9% | 0.00% | +100.0% |
| Q2 2018 | $969,000 | +1209.5% | 22,301 | +1024.6% | 0.00% | – |
| Q1 2018 | $74,000 | +105.6% | 1,983 | +6.4% | 0.00% | – |
| Q4 2017 | $36,000 | – | 1,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |